ConquerX Company
ConquerX is a biotechnology company that provides innovative molecular profiling solutions to clinical trials in precision medicine. The company's flagship product, the EbeGen, is an electro-chemical biosensor capable of detecting multiple molecular targets such as DNAs, RNAs, mirRNAs at the same time, without the need for sequencing and qPCR and at 10-time more cost effective compared to current technologies.
Total Funding:
81868
Headquarters:
Boston, Massachusetts, United States
Employee Number:
1-10
Last Funding Type:
Grant
Technology:
Other
Investor Type:
For Profit
Investors Number:
2
Founded Date:
2016-01-01
Industry:
BioTech